Podcast
Russell Reynolds Associates
Hosted by Russell Reynolds Associates · EN
Russell Reynolds Associates is a global leadership advisory and search firm, helping clients build transformational leadership to enhance the global business environment. Our 'Healthcare Leading Forward' series is singularly focused on improving the way the Healthcare world is led. We are honored to partner with highly impactful leaders from across the global ecosystem to discuss some of the most complex leadership issues facing healthcare today.
10episodes
Episodes
Newest firstAll episodes
Creating Value by Doing the Right Thing: Q&A with Thomas Leysen
Aug 30, 202100:26:57Tap to summarizeIn this podcast, Russell Reynolds' Jacques Bouwens, Managing Director in the Board and CEO Advisors Practice, and Filiep Deforche, Managing Director in the Board and CEO Advisors Practice and Leader of the firm's office in Belgium, speak with Thomas Leysen, the Chairman of Umicore, Chair of the Supervisory Board of Koninklijke DSM, Chairman of Mediahuis, and Chairman of the King Baudouin Foundation. Thomas shares his view on the evolution of sustainability and effective stakeholder engagement, how he led Umicore through its sustainability transformation, and his view for the future.
Transcribe →
Revitalizing Purpose: Q&A with Elcin Barker Ergun
Jan 21, 202100:18:34Tap to summarizeIn this podcast, Russell Reynolds' Alessandra Abate, Managing Director and Leader of the Global Biotech and Pharmaceuticals Practice, and Dana Krueger, Managing Director and Global Healthcare Sector Leader, speak with Elcin Barker Ergun, Chief Executive Officer at the Menarini Group. Elcin shares how Menarini has leveraged its strengths and revitalized its commitment to purpose during the COVID-19 pandemic.
Transcribe →
Shifting from a 'Me' to a 'We' view: Q&A with Marie-France Tschudin
Dec 14, 202000:18:15Tap to summarizeIn this podcast, Russell Reynolds' Markus Hofer, Managing Director and Senior Consultant in Healthcare Switzerland, and Dana M. Krueger, PhD, Managing Director and Global Healthcare Sector Leader, speak with Marie-France Tschudin, President of Novartis Pharmaceuticals. Marie-France shares how Novartis brings to life its aspirations of bringing its medicines to more patients, faster.
Transcribe →
The Purpose Blueprint: Q&A with Albert Bourla
Oct 23, 202000:18:33Tap to summarizeIn this podcast, Jacques Bouwens, a Senior Partner in the Global Healthcare Sector, and Sarah Galloway, a co-leader of the Sustainability Practice at Russell Reynolds Associates, speak with Dr. Albert Bourla, Chairman and Chief Executive Officer at Pfizer. Albert shares how Pfizer's recent decision to lead with purpose has transformed the way it conducts its business.
Transcribe →
Global Proof of Concept: Q&A with Paul Hudson
Oct 21, 202000:16:36Tap to summarizeIn this podcast, Dana Krueger, Managing Director and Global Healthcare Sector Leader, and Olivier Blin, Managing Director and Senior Consultant in Healthcare France at Russell Reynolds Associates, speak with Paul Hudson, the Chief Executive Officer at Sanofi. Paul shares how the pandemic has reinvigorated purpose and pace within his organization, and how he plans to maintain these positive effects in the future.
Transcribe →
Activating the Sustainability Agenda: Q&A with Deborah Dunsire
Oct 21, 202000:21:29Tap to summarizeIn this podcast, Diana Horn, Senior Consultant in the Leadership and Succession Practice, and Lars Rønn, Managing Director and Senior Consultant in Healthcare Nordics at Russell Reynolds Associates, speak with Dr. Deborah Dunsire, President and Chief Executive Officer at Lundbeck. Deborah shares how Lundbeck is increasingly bringing its production processes, supply chain, people management processes, and patient assistance programs into alignment with the United Nations' Sustainable Development Goals.
Transcribe →
The Other Way Around: Q&A with Kuen Loon Ho
Oct 21, 202000:16:42Tap to summarizeIn this episode, Dana Krueger, Managing Director and Global Healthcare Sector Leader, and Anupama Puranik, Managing Director and Senior Consultant in Healthcare Asia Pacific at Russell Reynolds Associates, speak with Kuen Loon Ho, the Group Chief Executive Officer at Singapore-based Fullerton Health, which owns and operates an extensive network of healthcare facilities across the Asia Pacific region. Kuen shares how the COVID-19 health crisis has helped the organization gain new clarity and connection around its long-standing purpose of providing affordable, accessible healthcare to all of Asia Pacific.
Transcribe →
Keeping a Long-Term View: Q&A with Geraldine O'Keeffe
Oct 21, 202000:16:22Tap to summarizeIn this podcast, Dana Krueger, Managing Director and Global Healthcare Sector Leader, and Alessandra Abate, Managing Director and Leader of the Global Biotech and Pharmaceuticals Practice at Russell Reynolds Associates, speak with Geraldine O'Keeffe, the Partner at LSP, one of Europe's largest biotech and healthcare investment firms. Geraldine shares what she has observed in both the public and private investment markets for healthcare companies, and what trends she expects to see in the future.
Transcribe →
Comfortable with Being Uncomfortable: Q&A with David Hale
Oct 21, 202000:17:48Tap to summarizeIn this podcast, Dana Krueger, Managing Director and Global Healthcare Sector Leader, and Olivier Blin, Managing Director and Senior Consultant in Healthcare France at Russell Reynolds Associates, speak with David Hale, the Group Chief Executive Officer at Guerbet, a global leader in imaging products and solutions based in France. David shares how COVID-19 has accelerated his transition period as CEO and helped his leaders create better engagement with their teams.
Transcribe →
Creative Collaboration: Q&A with Stéphane Bancel
Oct 21, 202000:23:06Tap to summarizeIn this podcast, Dana Krueger, Managing Director and Global Healthcare Sector Leader, and Rose Mistri-Somers, Executive Director and Senior Consultant in US Healthcare at Russell Reynolds Associates, speak with Stéphane Bancel, the Chief Executive Officer at Moderna, which is at the forefront of developing a vaccine against COVID-19. Stéphane shares how the biotechnology company has mobilized its force to create a vaccine more quickly than ever before.
Transcribe →